Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.00
Delayed Data
As of Feb 21
 -0.01 / -0.33%
Today’s Change
2.58
Today|||52-Week Range
5.66
+4.17%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close3.01
Today’s open3.02
Day’s range2.97 - 3.12
Volume1,836,189
Average volume (3 months)2,323,247
Market cap$413.6M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-36.30%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.21-0.91%
VSARVersartis Inc+0.03+1.47%
SGYPSynergy Pharmaceutic...-0.05-2.60%
INSYINSYS Therapeutics I...+0.34+4.48%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts